• Autolus Therapeutics to report second quarter 2023 financial results and host conference call on August 3, 2023

    ソース: Nasdaq GlobeNewswire / 18 7 2023 06:00:00   America/Chicago

    LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2023 financial results and operational highlights before open of US markets on Thursday, August 3, 2023.

    Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

    A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

    Contact:

    Julia Wilson
    +44 (0) 7818 430877
    j.wilson@autolus.com

    Susan A. Noonan
    S.A. Noonan Communications
    +1-917-513-5303
    susan@sanoonan.com

    Alexandra Deschner
    + +32-490-58-35-23
    a.deschner@autolus.com


    Primary Logo

シェアする